Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ling, Z.
Right arrow Articles by Pipeleers, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ling, Z.
Right arrow Articles by Pipeleers, D.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:2497-2502, 2003
© 2003 by the American Diabetes Association, Inc.

Variations in IB1/JIP1 Expression Regulate Susceptibility of ß-Cells to Cytokine-Induced Apoptosis Irrespective of C-Jun NH2-Terminal Kinase Signaling

Zhidong Ling1, Mark Van de Casteele1, Jing Dong1, Harry Heimberg1, Jacques-Antoine Haefliger2, Gérard Waeber2, Frans Schuit1, and Daniel Pipeleers1

1 Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium
2 Department of Internal Medicine B, University Hospital, Lausanne, Switzerland

We previously reported that interleukin-1ß (IL-1ß) alone does not cause apoptosis of ß-cells, whereas when combined with {gamma}-interferon (IFN-{gamma}) and tumor necrosis factor-{alpha} (TNF-{alpha}), it exerts a distinct apoptotic effect. Studies in ß-cell lines indicated that IL-1ß reduced expression of islet brain (IB)-1/JNK interacting protein (JIP)-1, a JNK scaffold protein with antiapoptotic action. We examined whether variations in IB1/JIP-1 expression in purified primary ß-cells affect their susceptibility to cytokine-induced apoptosis. Exposure to IL-1ß for 24 h decreased cellular IB1/JIP-1 content by 66 ± 17%; this IL-1ß effect was maintained in the presence of TNF-{alpha} + IFN-{gamma}, which did not influence IB1/JIP-1 levels by themselves. Addition of IL-1ß to TNF-{alpha} + IFN-{gamma} increased apoptosis from 20 ± 2% to 59 ± 5%. A similar increase in TNF-{alpha} + IFN-{gamma}-induced apoptosis was produced by adenoviral expression of antisense IB1/JIP-1 and was not further enhanced by addition of IL-1ß, indicating that IL-1ß-mediated suppression of IB1/JIP-1 in ß-cells increases their susceptibility to cytokine-induced apoptosis. However, adenovirally mediated overexpression of IB1/JIP-1 also potentiated TNF-{alpha} + IFN-{gamma}-induced apoptosis, suggesting that the antiapoptotic effect of IB1/JIP-1 depends on well-defined cellular levels. We conclude that the IB1/JIP-1 level in ß-cells can control their susceptibility to apoptosis independent of JNK signaling.


Address correspondence and reprint requests to Zhidong Ling, Diabetes Research Center, Brussels Free University-VUB, Laarbeeklaan 103, B-1090 Brussels, Belgium. E-mail: zhidong.ling{at}vub.ac.be


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. Ferdaoussi, S. Abdelli, J.-Y. Yang, M. Cornu, G. Niederhauser, D. Favre, C. Widmann, R. Regazzi, B. Thorens, G. Waeber, et al.
Exendin-4 Protects {beta}-Cells From Interleukin-1{beta}-Induced Apoptosis by Interfering With the c-Jun NH2-Terminal Kinase Pathway
Diabetes, May 1, 2008; 57(5): 1205 - 1215.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Chen, X. Li, and P. N. Epstein
MnSOD and Catalase Transgenes Demonstrate That Protection of Islets From Oxidative Stress Does Not Alter Cytokine Toxicity
Diabetes, May 1, 2005; 54(5): 1437 - 1446.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.